A significant quantity of Erythropoietin injections made in India and purchased for use by kidney disease patients, was seized by the Government Analyst, Food and Drug Department (GA-FDD), as the Indian manufacturers have reportedly been banned in the United States, but the Georgetown Public Hospital Corporation (GPHC) has since said that the entity acted rashly.
Both the GA-FDD Director Marlan Cole and the GPHC Director of Medical and Professional Services Dr Sheik Amir have confirmed the seizure which occurred on September 30 at the GPHC’s bond.
In a letter written to then Chief Executive Officer (CEO) Michael Khan days after the seizure, the GA-FDD said it was observed that Vintor-Erythropietin injection manufactured by Gennova Biopharmaceuticals Ltd, India and Wepox-Recombinant Human Erythropoietin injection manufactured by Wockhardt Limited, India were present in the bond.
